Science Explorer Back to mapMap
Discussion
Company · Abingdon · United Kingdom

PsiOxus Therapeutics (United Kingdom)

psioxus.comROR OpenAlex
Research works
40
▼ 4% vs 2018-21
Citations
1.1k
27.7 per fractional work
Top-10% rate
12.9%
all institutions 10.0%
Open access
53%
world 40%
International
43%
world 18%
PsiOxus Therapeutics (United Kingdom)

Not ranked overall: PsiOxus Therapeutics (United Kingdom) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does PsiOxus Therapeutics (United Kingdom) work in?

In all years, 62% of research at PsiOxus Therapeutics (United Kingdom) is in Life Sciences, 34% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (55%), Medicine (34%), Immunology and Microbiology (5%). It does 3.1× the world's share of Life Sciences.

Life Sciences: 25 fractional works · 62.0% of its workBiochemistry, Genetics and Molecular Biology: 22 fractional works · 55.4% of its workGenetics: 8 fractional works · 21.0% of its workMolecular Biology: 7 fractional works · 17.4% of its workBiotechnology: 5 fractional works · 13.4% of its workCancer Research: 1 fractional works · 3.0% of its workEndocrinology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 5.2% of its workImmunology: 2 fractional works · 4.8% of its workVirology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 0.7% of its workPlant Science: 0 fractional works · 0.4% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.4% of its workSensory Systems: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.3% of its workHealth Sciences: 14 fractional works · 33.8% of its workMedicine: 14 fractional works · 33.8% of its workOncology: 7 fractional works · 18.5% of its workPhysiology: 1 fractional works · 3.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.5% of its workEpidemiology: 1 fractional works · 2.1% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.9% of its workImmunology and Allergy: 0 fractional works · 1.0% of its workInfectious Diseases: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workSurgery: 0 fractional works · 0.3% of its workDermatology: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.7% of its workHealth Professions: 0 fractional works · 0.0% of its workPhysical Sciences: 2 fractional works · 3.8% of its workComputer Science: 1 fractional works · 1.7% of its workArtificial Intelligence: 0 fractional works · 0.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEngineering: 1 fractional works · 1.4% of its workBiomedical Engineering: 0 fractional works · 1.0% of its workComputational Mechanics: 0 fractional works · 0.4% of its workChemistry: 0 fractional works · 0.5% of its workSpectroscopy: 0 fractional works · 0.5% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.0% of its workSocial Sciences: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.4% of its workSociology and Political Science: 0 fractional works · 0.4% of its workALL ITS WORKPsiOxusTherapeutics…40fractional works, all years
Life Sciences62%Physical Sciences4%Health Sciences34%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2255.4%
    2. Immunology and Microbiology25.2%
    3. Agricultural and Biological Sciences00.7%
    4. Neuroscience00.4%
    5. Pharmacology, Toxicology and Pharmaceutics00.3%
    1. Medicine1433.8%
    2. Health Professions00.0%
    1. Computer Science11.7%
    2. Engineering11.4%
    3. Chemistry00.5%
    4. Physics and Astronomy00.1%
    5. Environmental Science00.0%
    1. Social Sciences00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 9.23× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 5.91× its world share, 1 worksImmunology and Micro…Neuroscience: 0.56× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.54× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.99× its world share, 0 worksChemistryComputer Science: 0.70× its world share, 1 worksComputer ScienceEngineering: 0.09× its world share, 0 worksEngineeringPhysics and Astronomy: 0.17× its world share, 0 worksPhysics and AstronomyMedicine: 1.80× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 9.2×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology9.23×6 works
  2. Immunology and Microbiology5.91×1 works
  3. Medicine1.80×4 works
  4. Pharmacology, Toxicology and Pharmaceutics1.54×0 works
  5. Chemistry0.99×0 works
  6. Computer Science0.70×1 works
  7. Neuroscience0.56×0 works
  8. Physics and Astronomy0.17×0 works
  9. Engineering0.09×0 works

Who are the top researchers at PsiOxus Therapeutics (United Kingdom)?

Ranked on the quality score, David Krige, John William Beadle and Hilary McElwaine-Johnn lead among researchers whose main affiliation is PsiOxus Therapeutics (United Kingdom).

  1. 1 David Krige United Kingdom · #1,171,171 worldwide 1.6k citations · 56 works
  2. 2 John William Beadle United Kingdom · #1,605,735 worldwide 1.2k citations · 38 works
  3. 3 Hilary McElwaine-Johnn United Kingdom · #1,746,318 worldwide 354 citations · 27 works
  4. 4 BRIAN R. CHAMPION United Kingdom · #1,786,119 worldwide 3.4k citations · 233 works
  5. 5 Manuela Zonca United Kingdom · #1,935,711 worldwide 332 citations · 60 works
  6. 6 Rochelle Lear United Kingdom · #3,619,351 worldwide 102 citations · 19 works
  7. 7 Christopher Ellis United Kingdom · #4,202,386 worldwide 93 citations · 18 works
  8. 8 Alice Brown United Kingdom · #4,342,579 worldwide 188 citations · 22 works
  9. 9 Sam Illingworth United Kingdom · #5,115,993 worldwide 319 citations · 27 works
All ranked researchers at PsiOxus Therapeutics (United Kingdom)

What are the most cited papers from PsiOxus Therapeutics (United Kingdom)?

The most cited paper from PsiOxus Therapeutics (United Kingdom) is "Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines" (Clotilde Théry et al., 2018), with 11,535 citations. Next come "Challenges and directions in studying cell–cell communication by extracellular vesicles" (1,245) and "A brief history of nearly EV‐erything – The rise and rise of extracellular vesicles" (584).

Most cited papers
#PaperReleasedCitations
1 Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors 23 Nov 2018 11,535
2 Challenges and directions in studying cell–cell communication by extracellular vesicles Guillaume van Niel, David R. F. Carter, Aled Clayton et al. · Nature Reviews Molecular Cell Biology ReviewOpen access 8 Mar 2022 1,245
3 A brief history of nearly EV‐erything – The rise and rise of extracellular vesicles Yvonne Couch, Edit I. Buzás, Dolores Di Vizio et al. · Journal of Extracellular Vesicles Open access Dec 2021 584
4 MIFlowCyt‐EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments Joshua A Welsh et al. · Journal of Extracellular Vesicles Open access 3 Feb 2020 527
5 Identification of storage conditions stabilizing extracellular vesicles preparations André Görgens et al. · Journal of Extracellular Vesicles Open access Jun 2022 425
All 59 most cited papers, with filters and sorting

Which keywords describe research at PsiOxus Therapeutics (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Immunotherapy, Tumor Regression, AAV, Viral Vectors, Cancer Immunotherapy, CAR T Cells and Chimeric Antigen Receptor.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. Gene Therapy15▲ 143×3 topics
  2. Immunotherapy12▲ 46×8 topics
  3. Tumor Regression12▲ 329×2 topics
  4. AAV8▲ 320×1 topic
  5. Viral Vectors8▲ 320×1 topic
  6. Cancer Immunotherapy7▲ 130×3 topics
  7. CAR T Cells6▲ 352×1 topic
  8. Chimeric Antigen Receptor6▲ 352×1 topic
  9. Tumor Targeting6▲ 104×2 topics
  10. Arginine Deprivation5▲ 306×1 topic
  11. Bacterial Therapy5▲ 306×1 topic
  12. Glycosylation3▲ 39×2 topics
  13. Cancer3▲ 5.7×13 topics
  14. Monoclonal Antibody3▲ 95×2 topics
  15. Mammalian Cells3▲ 167×1 topic
  16. Recombinant Protein3▲ 167×1 topic
  17. Inflammation2▲ 2.5×12 topics
  18. Biogenesis2▲ 48×3 topics
  19. Epidemiology2▲ 1.35×12 topics
  20. Biomarkers2▲ 8.4×3 topics
  21. Gene Silencing2▲ 33×2 topics
  22. RNA Interference1▲ 32×1 topic
  23. siRNA Delivery1▲ 47×1 topic
  24. Drug Delivery1▲ 7.0×2 topics
  25. Exosomes1▲ 117×1 topic
  26. Extracellular Vesicles1▲ 117×1 topic
  27. Treatment1▲ 2.5×4 topics
  28. Immunity1▲ 8.9×3 topics
  29. Antigen Presentation1▲ 28×2 topics
  30. Asthma1▲ 21×2 topics
  31. Genetics1▲ 3.7×3 topics
  32. Immunology1▲ 23×2 topics
  33. Innate Immunity1▲ 7.8×3 topics
  34. Allergic Diseases1▲ 33×1 topic
  35. Eosinophils1▲ 33×1 topic

Which research topics does PsiOxus Therapeutics (United Kingdom) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Virus-based gene therapy research, Viral Infectious Diseases and Gene Expression in Insects and Monoclonal and Polyclonal Antibodies Research.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksVirus-based gene therapy…2Virus-based gene therapy research: 2 fractional worksViral Infectious Diseases and Gene Expression in Insects: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksExtracellular vesicles i…1Extracellular vesicles in disease: 1 fractional worksCancer Research and Treatments: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksComputational Drug Discovery Methods: 0 fractional worksMicroRNA in disease regulation: 0 fractional worksBioinformatics and Genomic Networks: 0 fractional works
OncologyGeneticsMolecular BiologyRadiology, Nuclear Medicine and Imaging4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Virus-based gene therapy research Genetics 2 works
  3. 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  5. 5 Extracellular vesicles in disease Molecular Biology 1 works
  6. 6 Cancer Research and Treatments Biotechnology 0 works
  7. 7 Immunotherapy and Immune Responses Immunology 0 works
  8. 8 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  9. 9 MicroRNA in disease regulation Cancer Research 0 works
  10. 10 Bioinformatics and Genomic Networks Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.8%not open47.2%

World: 40% of research is openly available.

with international co-authors43.3%domestic only56.7%

World: 18% is written across borders.

How has PsiOxus Therapeutics (United Kingdom)'s research output changed?

Output in 2022-2025 was 4% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is PsiOxus Therapeutics (United Kingdom) as a percentage of every work published that year, 0.000016% in 2024.

still counting0.00010%0.00020%PsiOxus Therapeutics (United Kingdom)0.000025% in 202520102020

Fractional works of PsiOxus Therapeutics (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Abingdon

All research institutions in Abingdon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about PsiOxus Therapeutics (United Kingdom). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.